Category: Clinical Breakthroughs
-
Discovery Could Improve Survival of Bladder Cancer Patients
Northwestern Medicine scientists have developed a biomarker signature test to predict which tumors will respond to immunotherapy.
-
Combination Treatment Extends Progression-Free Survival in Pancreatic Cancers
A combination treatment approach using two chemotherapy drugs improved treatment response and progression-free survival in patients with advanced pancreatic neuroendocrine tumors, according to a recent clinical trial published in the Journal of Clinical Oncology.
-
Combination Treatment Extends Progression-Free Survival in Brain Cancer
Repeat radiation therapy combined with monoclonal antibody treatment extended progression-free survival in patients with recurrent glioblastoma, according to a recent clinical trial published in the Journal of Clinical Oncology.
-
Use Age, not Weight, to Screen for Diabetes
Focus on age, not weight, to capture the greatest number of people in all racial and ethnic groups with prediabetes and diabetes, reports a new Northwestern Medicine study published in the American Journal of Preventive Medicine.
-
New Combination of Drugs Works Together to Reduce Lung Tumors in Mice
Two therapeutic drugs benefited mice with non-small cell lung cancer, potentially paving the way for clinical trials in humans.
-
Self-Powered Wireless Implant Delivers Medication, Then Dissolves
Northwestern Medicine scientists have developed a wireless, self-powered, bioresorbable implant for programmed drug delivery, the details of which are published in PNAS.
-
Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma
Patients with advanced-stage melanoma who received immunotherapy both before and after surgery had longer event-free survival than patients who received immunotherapy only after surgery, according to a recent clinical trial published in the New England Journal of Medicine.
-
Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer
Combining a new hormone therapy drug with chemotherapy and another hormone therapy increased overall survival in patients with high-volume and both high-risk and low-risk metastatic hormone-sensitive prostate cancer, according to a post hoc analysis published in the Journal of Clinical Oncology.
-
New Directions for HIV Treatment
Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.
-
Predicting Risk of Blood Clots in Brain Tumors
Northwestern Medicine scientists have developed a new tool to predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas.
